Revista Peruana de Medicina Experimental y Salud Pública (Dec 2021)

Trends in drugs usage for COVID-19 during the first wave of the pandemic in a hospital in Lima, Peru

  • Nataly Echevarria-Castro,
  • Danitza Rojo Garcia,
  • Midori Torpoco Rivers,
  • Paola Rondán-Guerrero,
  • Frank García-Rojas,
  • Alvaro Taype-Rondan

DOI
https://doi.org/10.17843/rpmesp.2021.384.8820
Journal volume & issue
Vol. 38, no. 4
pp. 608 – 14

Abstract

Read online

This study aimed to evaluate the pharmacological trends in patients with COVID-19 from a hospital in Peru during the first wave of the pandemic. Retrospective study conducted between April and September 2020. The medical records of patients hospitalized for COVID-19 pneumonia at the Dos de Mayo National Hospital (Lima, Peru) were reviewed. Of a total of 3103 patients, 381 medical records were included (77.4% male, median age: 44 years). The use of four prehospital drugs increased (azithromycin, ivermectin, corticosteroids, and ceftriaxone), while the in-hospital use of six drugs (ceftriaxone, azithromycin, hydroxychloroquine, ivermectin, corticosteroid pulse, and prophylactic anticoagulation) decreased and in-hospital anticoagulation use decreased. These findings suggest that the management of COVID-19 has varied during the first wave of the pandemic, typically increasing prehospital drug use and decreasing inpatient use.

Keywords